Cargando…
Mouse gastric tumor models with prostaglandin E(2 )pathway activation show similar gene expression profiles to intestinal-type human gastric cancer
BACKGROUND: Gastric cancers are generally classified into better differentiated intestinal-type tumor and poorly differentiated diffuse-type one according to Lauren's histological categorization. Although induction of prostaglandin E(2 )pathway promotes gastric tumors in mice in cooperation wit...
Autores principales: | Itadani, Hiraku, Oshima, Hiroko, Oshima, Masanobu, Kotani, Hidehito |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2805698/ https://www.ncbi.nlm.nih.gov/pubmed/20015407 http://dx.doi.org/10.1186/1471-2164-10-615 |
Ejemplares similares
-
Can Systems Biology Understand Pathway Activation? Gene Expression Signatures as Surrogate Markers for Understanding the Complexity of Pathway Activation
por: Itadani, Hiraku, et al.
Publicado: (2008) -
Inflammation in gastric cancer: Interplay of the COX‐2/prostaglandin E(2) and Toll‐like receptor/MyD88 pathways
por: Echizen, Kanae, et al.
Publicado: (2016) -
Expression ratio of CCND1 to CDKN2A mRNA predicts RB1 status of cultured cancer cell lines and clinical tumor samples
por: Mizuarai, Shinji, et al.
Publicado: (2011) -
Functional loss of p53 cooperates with the in vivo microenvironment to promote malignant progression of gastric cancers
por: Ohtsuka, Junko, et al.
Publicado: (2018) -
Discovery of gene expression-based pharmacodynamic biomarker for a p53 context-specific anti-tumor drug Wee1 inhibitor
por: Mizuarai, Shinji, et al.
Publicado: (2009)